about
Increased prolactin levels are associated with impaired processing speed in subjects with early psychosisMorning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study.Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder.A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.The revised Temperament and Character Inventory: normative data by sex and age from a Spanish normal randomized sample.Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study.Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder.Psychosis and gender.Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyElevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study.Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.Clinical correlates of obsessive-compulsive symptom dimensions in at-risk mental states and psychotic disorders at early stages.Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis.Transmitting biological effects of stress in utero: implications for mother and offspring.Sex differences in the effect of childhood trauma on the clinical expression of early psychosis.Suicide in patients treated for obsessive-compulsive disorder: a prospective follow-up study.Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.Leptin, somatic depressive symptoms and the metabolic syndrome: a comment on Chirinos et al.A case-control study of sex differences in strategic processing and episodic memory in obsessive-compulsive disorder.Thyroglobulin antibodies and risk of readmission at one year in subjects with bipolar disorder.Higher psychoticism as a predictor of thoughts of harming one's infant in postpartum women: a prospective study.Individual versus group cognitive-behavioral treatment for obsessive-compulsive disorder: a controlled pilot study.Clinical implications of insight assessment in obsessive-compulsive disorder.Low-density lipoprotein cholesterol and suicidal behaviour in a large sample of first-episode psychosis patients.Sex differences in the relationship between prolactin levels and impaired processing speed in early psychosis.Improvement in cognitive abilities following cabergoline treatment in patients with a prolactin-secreting pituitary adenoma.Psychoneuroimmunology of mental disorders.Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.Gene-environment interaction between the brain-derived neurotrophic factor Val66Met polymorphism, psychosocial stress and dietary intake in early psychosis.The relationship between antidepressant treatment and inflammatory markers in early psychosis: preliminary results.Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial.Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia: Is there convergence with other clinical guidelines for the management of hyperprolactinaemia?Coping strategies for postpartum depression: a multi-centric study of 1626 women.Coping strategies and postpartum depressive symptoms: A structural equation modelling approach.Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin.Hypothalamic-pituitary-adrenal axis measures and cognitive abilities in early psychosis: Are there sex differences?Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes study.
P50
Q28540093-11457D99-6685-496A-AA0F-2779434B8451Q33751423-30B3E79F-66A5-4985-81AD-DACD2FA12D88Q34138587-6DC013D8-6348-443E-BF19-36C304F5AD32Q35795401-63F5050E-BA33-4C07-BC79-BACBCDF65328Q35880383-062D3C9C-2B88-4E5B-B725-7A8112A36BEBQ35926504-97FF4DBC-3709-4212-AD67-81AED3220A73Q36049118-81AE1A2D-5E8A-4A4A-A4CA-32BBCBDEE50DQ36168406-DCFB5D96-D630-4097-A6F6-21A3150C072BQ36168604-05456697-C84F-4815-B04D-ED85E7DD1661Q36580051-08CB82B8-9631-4847-B0E1-22BF680E9424Q37655205-616C88B8-568E-4BF2-8FAF-8EF5EDDF3EF3Q37677063-3CC49804-6B7F-4FD4-96D6-27E9F7C259A1Q38925904-5517032C-D551-4E0E-B133-D2D4F1DD4496Q38988115-8545910A-7EA2-40F5-92DB-ACA015673605Q39307906-23200440-2DF7-4401-866A-03A15EB34F4DQ39394347-9F8B3C4E-5ABC-4B26-B721-B30DE1BC48B9Q40731875-AA75537B-4C4B-4DB6-ADF3-33C99E880813Q43199086-CAA17EE4-D194-4241-AF0B-3A5AFAADDA7FQ44254015-CD77FB8A-F2F6-40FF-99F6-A124B52052C8Q44315376-B6C3759B-D1D4-4719-9248-8543D5C44E4FQ45171712-1FC4045D-C6C1-426D-B5D9-A6BA22DBB755Q45220293-9A493CD1-5ECF-49D6-80CF-2E1F6400C920Q45411786-63281A1F-AD2B-4CBF-91B8-14A8E12C3E6FQ46348188-DB855892-8232-4398-9757-5595C492FDCEQ46658281-3F179157-37A3-47D4-A032-858B23FFF921Q47564862-D4BECBCC-0E5C-4C8C-9F4C-C3D7271EF610Q47566044-FB14DFC2-DEAF-4155-A638-B314D3F3DBA8Q47596369-3A5EBB48-2A29-4D4D-A028-B2F61DFF4AA9Q47602188-3D97387A-E1A1-43AD-9E79-5E7B4859E0B9Q47794385-2EC8C088-3DF1-436D-A643-7C5F73FD6382Q47869127-C635471B-09D3-45E4-B6DA-DA5D49AA69ABQ47938228-711D23A4-D915-42C1-A644-237B4777F960Q47950709-D061EEEA-2DA5-4F30-AFF6-B07B8A3D7CC8Q47956104-9E1B3B61-634B-466D-9A62-E868696EAAA9Q47995646-2DFCB3A6-697B-4DC4-A320-370E8597E764Q48074164-BD2DEBFB-52A3-4412-8BE8-01A2884640B2Q48078789-8A098C30-D396-44FF-A707-902236D80C1BQ48426661-B910FDAB-207B-484E-BC19-835D9A005BA3Q48655849-351AB342-6BAE-445F-87C9-8EC9705E8F05Q48768927-FCFC964B-A810-4102-A61C-E4D04EA2214D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Javier Labad
@ast
Javier Labad
@en
Javier Labad
@es
Javier Labad
@nl
Javier Labad
@sl
type
label
Javier Labad
@ast
Javier Labad
@en
Javier Labad
@es
Javier Labad
@nl
Javier Labad
@sl
prefLabel
Javier Labad
@ast
Javier Labad
@en
Javier Labad
@es
Javier Labad
@nl
Javier Labad
@sl
P106
P1960
HFkykOwAAAAJ
P2038
Javier_Labad
P21
P31
P496
0000-0003-2214-1886
P569
2000-01-01T00:00:00Z